Amikacin
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
The University of Queensland
Overview
Amikacin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Amikacin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Amikacin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.